Author

Rahul Ohlan

The Graduate Center, CUNY

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Assay:scRNA-seq· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Approach:transformer / foundation model· 1

Frequent Co-Authors

Shuo ZhangiD· 2 shared Lei XieiD· 1 shared Lei XieiD· 1 shared Lixin XieiD· 1 shared Mohammadsadeq MottaqiiD· 1 shared Mohammedsadeq Mottaqi· 1 shared Raswanth Murugan· 1 shared Vikas Nallabolu· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Shuo ZhangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GEM-GPT Enables Personalized Cell Type-Resolved Therapeutic Design for Systems Pharmacology

Shuo Zhang, Rahul Ohlan, Mohammadsadeq Mottaqi, Lei Xie

GEM-GPT generates personalized therapeutic molecules to shift cell-type-specific disease states toward healthy phenotypes, outperforming baselines in chemical perturbation and CRISPR experiments.

bioRxiv · Sep 12, 2026 · PreprintPharmacology & Toxicology

MolGene-E: Inverse Molecular Design to Modulate Single Cell Transcriptomics

Rahul Ohlan, Raswanth Murugan, Lixin Xie, Vikas Nallabolu, Mohammedsadeq Mottaqi, Shuo Zhang, Lei Xie

MolGene-E generates high-quality drug molecules from single-cell transcriptomics data, outperforming baselines in zero-shot molecule generation.

bioRxiv · Feb 19, 2025 · PreprintBioinformatics